Infection prevention and control in residential facilities for pediatric patients and their families

Infection Control and Hospital Epidemiology

Volumn 34, Issue 10, 2013, Pages 1003-1041

  Guzman Cottrill, Judith A ^a   Ravin, Karen A ^b,g   Bryant, Kristina A ^c   Zerr, Danielle M ^d   Kociolek, Larry ^e   Siegel, Jane D ^f  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b GEISINGER MEDICAL CENTER   (United States)

^c University of Louisville School of Medicine   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^g NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CHICKENPOX VACCINE; HEPATITIS B VACCINE; HERPES ZOSTER IMMUNOGLOBULIN; PALIVIZUMAB;

ARTICLE; BEDBUG BITE; BREAST MILK; BREAST PUMP; CHICKENPOX; CLEANING; CLOSTRIDIUM DIFFICILE INFECTION; CYSTIC FIBROSIS; DIPHTHERIA; DISINFECTION; HEALTH SERVICE; HEPATITIS; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYGIENE; IMMUNOCOMPROMISED PATIENT; INFECTION; INFECTION CONTROL; MASS SCREENING; MEASLES; MENINGITIS; NONHUMAN; PEDIATRICS; PERTUSSIS; PRACTICE GUIDELINE; PREGNANCY; RESIDENTIAL HOME; RESPIRATORY TRACT DISEASE; TUBERCULOSIS; VACCINATION;

CROSS INFECTION; HOUSING; HUMANS; INFECTION CONTROL;

EID: 84884183225     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/673141     Document Type: Article

References (109)

1. Guzman-Cottrill JA, Bryant KA, Zerr DM, et al. Infection prevention and control guidance for Ronald McDonald Houses: a needs assessment. Infect Control Hosp Epidemiol 2012;33(3): 299-301.
2. Ronald McDonald House Charities. http://rmhc.org/what-we-do/ronald-mcdonald-house/the-history-of-the-house-that-love-built-2/. Cited March 11, 2012.
3. Adler AL, Casper C, Boeckh M, Heath J, Zerr DM. An outbreak of varicella with likely breakthrough disease in a population of pediatric cancer patients. Infect Control Hosp Epidemiol 2008; 29(9):866-870.
4. Federal Interagency Forum on Child and Family Statistics. http://www.childstats.gov/americaschildren/demo.asp. Cited March 11, 2012.
5. Perrin JM, Bloom SR, Gortmaker SL. The increase of childhood chronic conditions in the United States. JAMA 2007;297(24): 2755-2759.
6. Centers for Disease Control and Prevention. Deaths: final data for 2005. http://www.cdc.gov/nchs/data/nvsr/nvsr56/nvsr56 _10.pdf. Cited March 11, 2012.
7. Ries L, Smith M, Gurney J, et al. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995 [Internet]. 1999th ed. Bethesda, MD: National Cancer Institute, SEER Program. NIH Publication 99-4649.
8. Kulich M, Rosenfeld M, Goss CH, Wilmott R. Improved survival among young patients with cystic fibrosis. J Pediatr 2003; 142(6):631-636.
9. Siegel JD, Rhinehart E, Jackson M, Chiarello L; Health Care Infection Control Practices Advisory Committee. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 2007; 35(10 suppl 2):S65-S164.
10. Yokoe DS, Mermel LA, Anderson DJ, et al. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals. Infect Control Hosp Epidemiol 2008;29(suppl 1): S12-S21.
11. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep 2001;50(RR-5):1-43.
12. Saiman L, Siegel J; Cystic Fibrosis Foundation. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Infect Control Hosp Epidemiol 2003;24(5 suppl):S6-S52.
13. Guide to infection prevention for outpatient settings: minimum expectations for safe care. http://www.cdc.gov/HAI /settings/outpatient/outpatient-care-guidelines.html. Updated July 2011. Atlanta: Centers for Disease Control and Prevention, 2011.
14. Basic infection control and prevention plan for outpatient oncology settings. http://www.cdc.gov/hai/pdfs/guidelines/basic-infection-control-prevention-plan-2011.pdf. Atlanta: Centers for Disease Control and Prevention, 2011.
15. Healthcare Infection Control Practices Advisory Committee and Hand-Hygiene Task Force, Society for Healthcare Epidemiology of America, Association for Professionals in Infection Control and Epidemiology, Infection Diseases Society of America. Guideline for hand hygiene in healthcare settings. J Am Coll Surg 2004;198(1):121-127.
16. WHO guidelines on hand hygiene in health care. http:// whqlibdoc.who.int/publications/2009/9789241597906_eng.pdf. Geneva: World Health Organization, 2009.
17. Sandora TJ, Taveras EM, Shih MC, et al. A randomized, controlled trial of a multifaceted intervention including alcoholbased hand sanitizer and hand-hygiene education to reduce illness transmission in the home. Pediatrics 2005;116(3):587-594.
18. Talaat M, Afifi S, Dueger E, et al. Effects of hand hygiene campaigns on incidence of laboratory-confirmed influenza and absenteeism in schoolchildren, Cairo, Egypt. Emerg Infect Dis 2011;17(4):619-625.
19. White C, Kolble R, Carlson R, et al. The effect of hand hygiene on illness rate among students in university residence halls. Am J Infect Control 2003;31(6):364-370.
20. Mott PJ, Sisk BW, Arbogast JW, Ferrazzano-Yaussy C, Bondi CA, Sheehan JJ. Alcohol-based instant hand sanitizer use in military settings: a prospective cohort study of army basic trainees. Mil Med 2007;172(11):1170-1176.
21. Guidelines for environmental infection control in health-care facilities: recommendations of the Centers for Disease Control and Prevention and the Healthcare Infection Control Practices Advisory Committee (HICPAC). http://www.cdc.gov/hicpac /pdf/guidelines/eic_in_HCF_03.pdf. Cited March 21, 2012.
22. Bean B, Moore BM, Sterner B, Peterson LR, Gerding DN, Balfour HH Jr. Survival of influenza viruses on environmental surfaces. J Infect Dis 1982;146(1):47-51.
23. American Academy of Pediatrics. Infection control measures. In: Aronson SA, Shope TR, eds. Managing Infectious Diseases in Child Care and Schools: A Quick Reference Guide. Elk Grove Village, IL: American Academy of Pediatrics, 2008:17-30.
24. Gartner LM, Morton J, Lawrence RA, et al. Breastfeeding and the use of human milk. Pediatrics 2005;115(2):496-450.
25. Zeilhofer UB, Frey B, Zandee J, Bernet V. The role of critical incident monitoring in detection and prevention of human breast milk confusions. Eur J Pediatr 2009;168(10):1277-1279.
26. Centers for Disease Control and Prevention. What to do if an infant or child is mistakenly fed another woman's breast milk. http://www.cdc.gov/breastfeeding/recommendations/other _mothers_milk.htm. Cited March 12, 2012.
27. Goddard J, deShazo R. Bed bugs (Cimex lectularius) and clinical consequences of their bites. JAMA 2009;301(13):1358-1366.
28. Centers for Disease Control and Prevention, US Environmental Protection Agency. Joint statement on bed bug control in the United States from the U.S. Centers for Disease Control and Prevention (CDC) and the U.S. Environmental Protection Agency (EPA). http://www.cdc.gov/nceh/ehs/publications/bed _bugs_cdc-epa_statement.htm. Atlanta: US Department of Health and Human Services, 2010.
29. Dubberke ER, Gerding DN, Classen D, et al. Strategies to prevent Clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol 2008;29(suppl 1):S81-S92.
30. Simor AE, Bradley SF, Strausbaugh LJ, Crossley K, Nicolle LE; SHEA Long-Term-Care Committee. Clostridium difficile in long-term-care facilities for the elderly. Infect Control Hosp Epidemiol 2002;23(11):696-703.
31. American Academy of Pediatrics. Clostridium difficile. In: Pickering L, Baker C, Kimberlin D, Long S, eds. Red Book: 2012 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics, 2012:285-287.
32. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31(5):431-455.
33. National Nosocomial Infections Surveillance (NNIS) system report, data summary from October 1986-April 1998, issued June 1998. Am J Infect Control 1998;26(5):522-533.
34. Brito DV, Oliveira EJ, Matos C, Abdallah VO, Gontijo Filho PP. An outbreak of conjunctivitis caused by multiresistant Pseudomonas aeruginosa in a Brazilian newborn intensive care unit. Braz J Infect Dis 2003;7(4):234-235.
35. Haas J, Larson E, Ross B, See B, Saiman L. Epidemiology and diagnosis of hospital-acquired conjunctivitis among neonatal intensive care unit patients. Pediatr Infect Dis J 2005;24(7):586-589.
36. Ariga T, Shimada Y, Ohgami K, et al. New genome type of adenovirus serotype 4 caused nosocomial infections associated with epidemic conjunctivitis in Japan. J Clin Microbiol 2004; 42(8):3644-3648.
37. Wu D, Ke CW, Mo YL, et al. Multiple outbreaks of acute hemorrhagic conjunctivitis due to a variant of coxsackievirus A24: Guangdong, China, 2007. J Med Virol 2008;80(10):1762-1768.
38. Centers for Disease Control and Prevention. Acute hemorrhagic conjunctivitis outbreak caused by coxsackievirus A24-Puerto Rico, 2003. MMWRMorb Mortal Wkly Rep 2004;53(28): 632-634.
39. Park K, Lee K, Lee J, et al. Acute hemorrhagic conjunctivitis epidemic caused by coxsackievirus A24 variants in Korea during 2002-2003. J Med Virol 2006;78(1):91-97.
40. Centers for Disease Control and Prevention. Pneumococcal conjunctivitis at an elementary school-Maine, September 20-December 6, 2002. MMWR Morb Mortal Wkly Rep 2003;52(4): 64-66.
41. Martin M, Turco JH, Zegans ME, et al. An outbreak of conjunctivitis due to atypical Streptococcus pneumoniae. N Engl J Med 2003;348(12):1112-1121.
42. Crum NF, Barrozo CP, Chapman FA, Ryan MA, Russell KL. An outbreak of conjunctivitis due to a novel unencapsulated Streptococcus pneumoniae among military trainees. Clin Infect Dis 2004;39(8):1148-1154.
43. Ong AE, Dashraath P, Lee VJ. Management of enteroviral conjunctivitis outbreaks in the Singapore military in 2005. Southeast Asian J Trop Med Public Health 2008;39(3):398-403.
44. American Academy of Pediatrics. School health. In: Pickering L, Baker C, Kimberlin D, Long S, eds. Red Book: 2012 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics, 2012:152-160.
45. Centers for Disease Control and Prevention. Updated norovirus outbreak management and disease prevention guidelines. MMWR 2011;60(RR-3):1-12.
46. American Academy of Pediatrics. Rotavirus. In: Pickering L, Baker C, Kimberlin D, Long S, eds. Red Book: 2012 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics, 2012:626-629.
47. American Academy of Pediatrics. Diphtheria. In: Pickering L, Baker C, Kimberlin D, Long S, eds. Red Book: 2012 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics, 2012:307-311.
48. American Academy of Pediatrics. Hepatitis A. In: Pickering L, Baker C, Kimberlin D, Long S, eds. Red Book: 2012 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics, 2012:361-369.
49. American Academy of Pediatrics. Hepatitis B. In: Pickering L, Baker C, Kimberlin D, Long S, eds. Red Book: 2012 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics, 2012:369-390.
50. Weinbaum CM, Williams I, Mast EE, et al; Centers for Disease Control and Prevention. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep 2008;57(RR-8): 1-20.
51. American Academy of Pediatrics. Hepatitis C. In: Pickering L, Baker C, Kimberlin D, Long S, eds. Red Book: 2012 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics, 2012:391-395.
52. Hepatitis C virus infection. American Academy of Pediatrics. Committee on infectious diseases. Pediatrics 1998;101(3 pt 1): 481-485.
53. American Academy of Pediatrics. Human immunodeficiency virus infection. In: Pickering L, Baker C, Kimberlin D, Long S, eds. Red Book: 2012 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics, 2012:418-439.
54. American Academy of Pediatrics Task Force on Pediatric AIDS. Pediatric guidelines for infection control of human immunodeficiency virus (acquired immunodeficiency virus) in hospitals, medical offices, schools, and other settings. Pediatrics 1988;82(5):801-807.
55. American Academy of Pediatrics. Herpes simplex. In: Pickering L, Baker C, Kimberlin D, Long S, eds. Red Book: 2012 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics, 2012:398-408.
56. American Academy of Pediatrics. Pediculosis capitis (head lice). In: Pickering L, Baker C, Kimberlin D, Long S, eds. Red Book: 2012 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics, 2012:543-546.
57. Frankowski BL, Bocchini JA Jr; Council on School Health and Committee on Infectious Diseases. Head lice. Pediatrics 2010; 126(2):392-403.
58. American Academy of Pediatrics. Measles. In: Pickering L, Baker C, Kimberlin D, Long S, eds. Red Book: 2012 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics, 2012:489-499.
59. American Academy of Pediatrics. Haemophilus influenza infections. In: Pickering L, Baker C, Kimberlin D, Long S, eds. Red Book: 2012 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics, 2012: 345-352.
60. American Academy of Pediatrics. Meningococcal infections. In: Pickering L, Baker C, Kimberlin D, Long S, eds. Red Book: 2012 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics, 2012:500-509.
61. American Academy of Pediatrics. Enterovirus (nonpoliovirus) infections. In: Pickering L, Baker C, Kimberlin D, Long S, eds. Red Book: 2012 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics, 2012: 315-318.
62. Fritz SA, Krauss MJ, Epplin EK, et al. The natural history of contemporary Staphylococcus aureus nasal colonization in community children. Pediatr Infect Dis J 2011;30(4):349-351.
63. Lacey S, Flaxman D, Scales J, Wilson A. The usefulness of masks in preventing transient carriage of epidemic methicillin-resistant Staphylococcus aureus by healthcare workers. J Hosp Infect 2001;48(4):308-311.
64. Gray JW, George RH. Experience of vancomycin-resistant enterococci in a children's hospital. J Hosp Infect 2000;45(1):11-18.
65. Tsiatis AC, Manes B, Calder C, Billheimer D, Wilkerson KS, Frangoul H. Incidence and clinical complications of vancomycin-resistant enterococcus in pediatric stem cell transplant patients. Bone Marrow Transplant 2004;33(9):937-941.
66. American Academy of Pediatrics. Mumps. In: Pickering L, Baker C, Kimberlin D, Long S, eds. Red Book: 2012 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics, 2012:514-518.
67. Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study. Br Med J (Clin Res Ed) 1988;296(6622):612-614.
68. Cherry JD. Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin Infect Dis 1999;28(suppl 2):S112-S117.
69. Bryant KA, Humbaugh K, Brothers K, et al. Measures to control an outbreak of pertussis in a neonatal intermediate care nursery after exposure to a healthcare worker. Infect Control Hosp Epidemiol 2006;27(6):541-545.
70. Khetsuriani N, Bisgard K, Prevots DR, et al. Pertussis outbreak in an elementary school with high vaccination coverage. Pediatr Infect Dis J 2001;20(12):1108-1112.
71. Srugo I, Benilevi D, Madeb R, et al. Pertussis infection in fully vaccinated children in day-care centers, Israel. Emerg Infect Dis 2000;6(5):526-529.
72. Fisher MC, Long SS, McGowan KL, Kaselis E, Smith DG. Outbreak of pertussis in a residential facility for handicapped people. J Pediatr 1989;114(6):934-939.
73. Yeh J, Batt RE. Contingency plans and the sniffles. Acad Med 2006;81(4):325.
74. Guidelines for the control of pertussis outbreaks. http:// www.cdc.gov/vaccines/pubs/pertussis-guide/guide.htm. Atlanta: Centers for Disease Control and Prevention, 2000.
75. Bisgard KM, Pascual FB, Ehresmann KR, et al. Infant pertussis: who was the source? Pediatr Infect Dis J 2004;23(11):985-989.
76. Kretsinger K, Broder KR, Cortese MM, et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of tdap among healthcare personnel. MMWR Recomm Rep 2006;55(RR-17):1-37.
77. Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009;360(6):588-589.
78. Nichols WG, Gooley T, Boeckh M. Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center experience. Biol Blood Marrow Transplant 2001;7(suppl):11S-15S.
79. Harrington RD, Hooton TM, Hackman RC, et al. An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis 1992;165(6):987-993.
80. American Academy of Pediatrics. Scabies. In: Pickering L, Baker C, Kimberlin D, Long S, eds. Red Book: 2012 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics, 2012:641-643.
81. Obasanjo OO, Wu P, Conlon M, et al. An outbreak of scabies in a teaching hospital: lessons learned. Infect Control Hosp Epidemiol 2001;22(1):13-18.
82. Andersen BM, Haugen H, Rasch M, Heldal Haugen A, Tageson A. Outbreak of scabies in Norwegian nursing homes and home care patients: control and prevention. J Hosp Infect 2000;45(2): 160-164.
83. Centers for Disease Control and Prevention. Parasites-scabies: institutional settings. http://www.cdc.gov/parasites/scabies /health_professionals/institutions.html. Cited March 15, 2012. Accessed January 8, 2013.
84. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005;41(10):1373-1406.
85. Association for Professionals in Infection Control and Epidemiology. Guide to the elimination of methicillin-resistant Staphylococcus aureus (MRSA) transmission in hospital settings. 2nd ed. 2010. http://www.apic.org/Resource_/Elimination GuideForm/631fcd91-8773-4067-9f85-ab2a5b157eab/File /MRSA-elimination-guide-2010.pdf. Accessed January 8, 2013.
86. Association for Professionals in Infection Control and Epidemiology. Guide to the elimination of methicillin-resistant Staphylococcus aureus (MRSA) in the long-term care facility. 2009. http://www.apic.org/Resource_/EliminationGuideForm /08b12595-9f92-4a64-ad41-4afdd0088224/File/APIC-MRSA-in-Long-Term-Care.pdf. Accessed January 8, 2013.
87. Calfee DP, Salgado CD, Classen D, et al. Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals. Infect Control Hosp Epidemiol 2008; 29(suppl 1):S62-S80.
88. American Academy of Pediatrics. Group A streptococcal infections. In: Pickering L, Baker C, Kimberlin D, Long S, eds. Red Book: 2012 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics, 2012: 668-680.
89. Jensen PA, Lambert LA, Iademarco MF, Ridzon R; Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 2005;54(RR-17):1-141.
90. American Academy of Pediatrics. Tuberculosis. In: Pickering L, Baker C, Kimberlin D, Long S, eds. Red Book: 2012 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics, 2012:736-759.
91. American Academy of Pediatrics. Varicella-zoster infections. In: Pickering L, Baker C, Kimberlin D, Long S, eds. Red Book: 2012 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics, 2012:774-789.
92. Langley JM, Hanakowski M. Variation in risk for nosocomial chickenpox after inadvertent exposure. J Hosp Infect 2000; 44(3):224-226.
93. Ross AH. Modification of chicken pox in family contacts by administration of gamma globulin. N Engl J Med 1962;267: 369-376.
94. Saidel-Odes L, Borer A, Riesenberg K, et al. An outbreak of varicella in staff nurses exposed to a patient with localized herpes zoster. Scand J Infect Dis 2010;42(8):620-622.
95. Lopez AS, Burnett-Hartman A, Nambiar R, et al. Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004. J Infect Dis 2008;197(5):646-653.
96. Marin M, Guris D, Chaves SS, Schmid S, Seward JF; Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007;56(RR-4):1-40.
97. Price CS, Thompson WW, Goodson B, et al. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics 2010;126(4):656-664.
98. Immunization Safety Review Committee. Front matter. Immunization Safety Review: Vaccines and Autism. Washington, DC: National Academies Press, 2004.
99. Talbot TR. Revised SHEA position paper: influenza vaccination of healthcare personnel. Infect Control Hosp Epidemiol 2010; 31:987.
100. Puig-Barbera J. Reduction in hospital admissions for pneumonia in non-institutionalised elderly people as a result of influenza vaccination: a case-control study in Spain. J Epidemiol Community Health 1997;51:526.
101. Reichert TA. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 2001;344:889.
102. Piedra PA. Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine 2005;23:1540.
103. Loeb M. Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA 2010;303:943.
104. Grizas AP, Camenga D, Vázquez M. Cocooning: a concept to protect young children from infectious diseases. Curr Opin Pediatr 2012;24(1):92-97.
105. Lynch JP 3rd, Zhanel GG. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines. Curr Opin Pulm Med 2010;16(3):217-225.
106. Centers for Disease Control and Prevention. FDA approval of expanded age indication for a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine. MMWR 2011; 60(37):1279-1280.
107. Centers for Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months-Advisory Committee on Immunization Practices (ACIP), 2011. MMWR 2011; 60(41):1424-1426.
108. Centers for Disease Control and Prevention. Achievements in public health, 1900-1999 impact of vaccines universally recommended for children-United States, 1990-1998. MMWR 1999;48(12):243-248.
109. College of Physicians of Philadelphia. Vaccine development, testing, and regulation-history of vaccines. http://www.historyofvaccines.org/content/articles/vaccine-development-testing-and-regulation. Accessed November 12, 2012.